Oxidative metabolism deficiencies in brains of patients with Alzheimer's disease

Acta Neurologica Scandinavica

Volumn 94, Issue SUPPL.165, 1996, Pages 18-24

  Hoyer, Siegfried ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Alzheimer's disease; Brain; Glucose; Glucose metabolism; Insulin; Insulin receptor; Sporadic late onset dementia of Alzheimer type

Indexed keywords

AMYLOID PRECURSOR PROTEIN; INSULIN RECEPTOR; GLUCOSE;

ALZHEIMER DISEASE; BRAIN METABOLISM; CONFERENCE PAPER; DEMENTIA; GLUCOSE METABOLISM; HUMAN; HUMAN TISSUE; BRAIN; METABOLISM; REVIEW;

ALZHEIMER DISEASE; BRAIN; GLUCOSE; HUMANS;

EID: 0029689159     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1996.tb05868.x     Document Type: Article

References (90)

1. Farrer LA, Myers RH, Cupples LA et al. Transmission and age-at-onset patterns in familial Alzheimer's disease: evidence for heterogeneity. Neurology 1990: 40: 395-403.
2. Hardy J., Mullan M., Chartier Harlin MC et al. Molecular classification of Alzheimer's disease [letter]. Lancet 1991: 337: 1342-43.
3. Pericak-Vance MA, Bebout JL, Gaskell PC Jr et al. Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. Am J Hum Genet 1991: 48: 1034-50.
4. St. George-Hyslop PH, Haines JL, Farrer LA et al. Genetic linkage studies suggest that Alzheimer's disease is not a single homogeneous disorder. FAD Collaborative Group. Nature 1990: 347: 194-97.
5. Tanzi RE, St. George-Hyslop P., Gusella JF. Molecular genetics of Alzheimer disease amyloid. J Biol Chem 1991: 266: 20579-82.
6. Tanzi RE, Vaula G., Romano DM et al. Assessment of amyloid beta-protein precursor gene mutations in a large set of familial and sporadic Alzheimer disease cases. Am J Hum Genet 1992: 51: 273-82.
7. Gottfries CG. Alzheimer's disease and senile dementia: biochemical characteristics and aspects of treatment. Psychopharmacology (Berl) 1985: 86: 245-52.
8. Evans DA, Funkenstein HH, Albert MS et al. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA 1989: 262: 2551-56.
9. Bak P., Tang C., Wiesenfeld K. Self-organized criticality. Physic Rev A 1988: 38: 364-74.
10. Held GA, Solina DH, Keane DT, Haag WJ, Horn PM, Grinstein G. Experimental study of critical-mass fluctuations in an evolving sandpile. Phys Rev Lett 1990: 69: 1120-23.
11. Storandt M., Aufdembrinke B., Bäckman L. et al. Relationship of normal aging and dementing diseases in later life. In: Henderson AS, Henderson JH, eds. Etiology of dementia of Alzheimer's type. Chichester, England: John Wiley & Sons, 1988: 231-39.
12. Hoyer S. The biology of the aging brain. Oxidative and related metabolism. Eur J Gerontol 1992: 1: 157-62.
13. Gibson GE, Jope R., Blass JP. Decreased synthesis of acetylcholine accompanying impaired oxidation of pyruvic acid in rat brain minces. Biochem J 1975: 148: 17-23.
14. 14C)glucose by tissue prisms from human neocortex. Biochem J 1981: 196: 867-76.
15. Wong KL, Tyce GM. Glucose and amino acid metabolism in rat brain during sustained hypoglycemia. Neurochem Res 1983: 8: 401-15.
16. Erecińska M., Silver IA. ATP and brain function. J Cereb Blood Flow Metab 1989: 9: 2-19.
17. Hoyer S. Oxidative energy metabolism in Alzheimer brain. Studies in early-onset and late-onset cases. Mol Chem Neuropathol 1992: 16: 207-24.
18. Huganir RL, Greengard P. Regulation of neurotransmitter receptor desensitization by protein phosphorylation. Neuron 1990: 5: 555-67.
19. Kadekaro M., Crane AM, Sokoloff L. Differential effects of electrical stimulation of sciatic nerve on metabolic activity in spinal cord and dorsal root ganglion in the rat. Proc Natl Acad Sci USA 1985: 82: 6010-13.
20. Braakman I., Helenius J., Helenius A. Role of ATP and disulphide bonds during protein folding in the endoplasmic reticulum. Nature 1992: 356: 260-62.
21. Gething MJ, Sambrook J. Protein folding in the cell. Nature 1992: 355: 33-45.
22. Ehrlich YH, Davis TB, Bock E., Kornecki E., Lenox RH. Ecto-protein kinase activity on the external surface of neural cells. Nature 1986: 320: 67-70.
23. Greengard P. Phosphorylated proteins as physiological effectors. Science 1978: 199: 146-52.
24. Chiang HL, Terlecky SR, Plant CP, Dice JF. A role for a 70-kilodalton heat shock protein in lysosomal degradation of intracellular proteins. Science 1989: 246: 382-85.
25. Okada M., Ishikawa M., Mizushima Y. Identification of a ubiquitin- and ATP-dependent protein degradation pathway in rat cerebral cortex. Biochim Biophys Acta 1991: 1073: 514-20.
26. Siesjö BK. Cell damage in the brain: a speculative synthesis. J Cereb Blood Flow Metab 1981: 1: 155-85.
27. Burnstock G. Overview. Purinergic mechanisms. Ann NY Acad Sci 1990: 603: 1-17.
28. Edwards FA, Gibb AJ, Colquhoun D. ATP receptor-mediated synaptic currents in the central nervous system. Nature 1992: 359: 144-47.
29. Neary JT, Whittemore SR, Zhu Q., Norenberg MD. Synergistic activation of DNA synthesis in astrocytes by fibroblast growth factors and extracellular ATP. J Neurochem 1994: 63: 490-94.
30. Hoyer S., Oesterreich K., Wagner O. Glucose metabolism as the site of the primary abnormality in early-onset dementia of Alzheimer type J Neurol 1988: 235: 143-48.
31. Hoyer S., Nitsch R., Oesterreich K. Predominant abnormality in cerebral glucose utilization in late-onset dementia of the Alzheimer type: a cross-sectional comparison against advanced late-onset and incipient early-onset cases. J Neural Transm (P-D Sect) 1991: 3: 1-14.
32. Hoyer S. The effect of age on glucose and energy metabolism in brain cortex of rats. Arch Gerontol Geriatr 1985: 4: 193-203.
33. Hoyer S., Krier C. Ischemia and the aging brain. Studies on glucose and energy metabolism in rat cerebral cortex. Neurobiol Aging 1986: 7: 23-29.
34. Dutschke K., Nitsch RM, Hoyer S. Short-term mental activation accelerates the age-related decline in brain tissue levels of high energy phosphates. Arch Gerontol Geriatr 1994: 19: 43-51.
35. Dastur DK. Cerebral blood flow and metabolism in normal human aging, pathological aging, and senile dementia. J Cereb Blood Flow Metab 1985: 5: 1-9.
36. Gibson GE, Peterson C. Aging decreases oxidative metabolism and the release and synthesis of acetylcholine. J Neurochem 1981: 37: 978-84.
37. Oldstone MBA, Holmstoen J., Welsh RM Jr. Alterations of acetylcholine enzymes in neuroblastoma cells persistently infected with lymphocytic choriomeningitis virus. J Cell Physiol 1977: 91: 459-72.
38. Benzi G., Pastoris O., Villa RF, Giuffrida AM. Effect of aging on cerebral cortex energy metabolism in hypoglycemia and posthypoglycemic recovery. Neurobiol Aging 1984: 5: 205-12.
39. Hoyer S., Betz K. Abnormalities in glucose and energy metabolism are more severe in the hippocampus than in cerebral cortex in postischemic recovery in aged rats. Neurosci Lett 1988: 94: 167-72.
40. Degrell I., Krier C., Hoyer S. Carbohydrate and energy metabolism of the aging rat brain in severe arterial hypoxemia. In: Cervós-Navarro J., Sarkander HI, eds. Brain aging: neuropathology and neuropharmacology. New York: Raven Press 1983: 289-300.
41. Nohl H., Krämer R. Molecular basis of age-dependent changes in the activity of adenine nucleotide translocase. Mech Ageing Dev 1980: 14: 137-44.
42. Kim JH, Shrago E., Elson CE. Age-related changes in respiration coupled to phosphorylation. II. Cardiac mitochondria. Mech Ageing Dev 1988: 46: 279-90.
43. Hoyer S. Age as risk factor for sporadic dementia of the Alzheimer type Ann NY Acad Sci 1994: 719: 248-56.
44. Häring HU. The insulin receptor: signalling mechanism and contribution to the pathogenesis of insulin resistance. Diabetologia 1991: 34: 848-61.
45. Goldstein BJ. Regulation of insulin receptor signaling by protein-tyrosine dephosphorylation. Receptor 1993: 3: 1-15.
46. Häring H., Kirsch D., Obermaier B., Ermel B., Machicao F. Decreased tyrosine kinase activity of insulin receptor isolated from rat adipocytes rendered insulin-resistant by catecholamine treatment in vitro. Biochem J 1986: 234: 59-66.
47. Giorgino F., Almahfouz A., Goodyear LJ, Smith RJ. Glucocorticoid regulation of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat skeletal muscle in vivo. J Clin Invest 1993: 91: 2020-30.
48. Turnbow MA, Keller SR, Rice KM, Garner CW. Dexamethasone down-regulation of insulin receptor substrate-1 in 3T3-L1 adipocytes. J Biol Chem 1994: 269: 2516-20.
49. Unger JW, Livingston JN, Moss AM. Insulin receptors in the central nervous system: localization, signalling mechanisms and functional aspects. Prog Neurobiol 1991: 36: 343-62.
50. Devaskar SU, Giddings SJ, Rajakumar PA, Carnaghi LR, Menon RK, Zahm DS. Insulin gene expression and insulin synthesis in mammalian neuronal cells. J Biol Chem 1994: 269: 8445-54.
51. Hill JM, Lesniak MA, Pert CB, Roth J. Autoradiographic localization of insulin receptors in rat brain: prominence in olfactory and limbic areas. Neuroscience 1986: 17: 1127-38.
52. Baskin DG, Schwartz MW, Sipols AJ, D'Alessio DA, Goldstein BJ, White MF. Insulin receptor substrate-1 (IRS-1) expression in rat brain. Endocrinology 1994: 134: 1952-55.
53. Hoyer S., Prem L., Sorbi S., Amaducci L. Stimulation of glycolytic key enzymes in cerebral cortex by insulin. Neuro Report 1993: 4: 991-93.
54. Rinaudo MT, Curto M., Bruno R. Effect of insulin on the pyruvate dehydrogenase complex in the rat brain. Ital J Biochem 1985: 34: 229-37.
55. Kyriakis JM, Hausman RE, Peterson SW. Insulin stimulates choline acetyltransferase activity in cultured embryonic chicken retina neurons. Proc Natl Acad Sci USA 1987: 84: 7463-67.
56. Henneberg N., Hoyer S. Short-term or long-term intracerebroventricular (i.c.v.) infusion of insulin exhibits a discrete anabolic effect on cerebral energy metabolism in the rat. Neurosci Lett 1994: 175: 153-56.
57. Duelli R., Schröck H., Kuschinsky W., Hoyer S. Intracerebroventricular injection of streptozotocin induces discrete local changes in cerebral glucose utilization in rats. Int J Dev Neurosci 1994: 12: 737-43.
58. Plaschke K., Hoyer S. Action of the diabetogenic drug streptozotocin on glycolytic and glycogenolytic metabolism in adult rat brain cortex and hippocampus. Int J Dev Neurosci 1993: 11: 477-83.
59. Nitsch R., Hoyer S. Local action of the diabetogenic drug, streptozotocin, on glucose and energy metabolism in rat brain cortex. Neurosci Lett 1991: 128: 199-202.
60. Plaschke K., Muller D., Hoyer S. Effect of adrenalectomy and corticosterone substitution on glucose and glycogen metabolism in rat brain. J Neural Transm (in press).
61. Mielke R., Herholz K., Grond M., Kessler J., Heiss WD. Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer type. Neurobiol Aging 1992: 13: 93-98.
62. Kumar A., Schapiro MB, Grady C. et al. High-resolution PET studies in Alzheimer's disease. Neuropsychopharmacology 1991: 4: 35-46.
63. Frackowiak RS, Pozzilli C., Legg NJ et al. Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography. Brain 1981: 104: 753-78.
64. Fukuyama H., Ogawa M., Yamauchi H. et al. Altered cerebral energy metabolism in Alzheimer's disease: a PET study. J Nucl Med 1994: 35: 1-6.
65. de la Torre JC. Impaired brain microcirculation may trigger Alzheimer's disease. Neurosci Biobehav Rev 1994: 18: 397-401.
66. Norberg K., Siesjö BK. Oxidative metabolism of the cerebral cortex of the rat in severe insulin-induced hypoglycaemia. J Neurochem 1976: 26: 345-52.
67. Pettegrew JW, Panchalingam K., Klunk WE, McClure RJ, Muenz LR. Alterations of cerebral metabolism in probable Alzheimer's disease: a preliminary study. Neurobiol Aging 1994: 15: 117-32.
68. Hoyer S. Glucose and related brain metabolism in dementia of Alzheimer type and its morphological significance. Age 1988: 11: 158-66.
69. Hoyer S. Sporadic dementia of Alzheimer type: role of amyloid in etiology is challenged. J Neural Transm (P-D Sect) 1993: 6: 159-65.
70. Nitsch RM, Slack BE, Wurtman RJ, Growdon JH. Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 1992: 258: 304-7.
71. Gabuzda D., Busciglio J., Chen LB, Matsudaira P., Yankner BA. Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative. J Biol Chem 1994: 269: 13623-28.
72. Sapolsky RM, Krey LC, McEwen BS. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocrin Rev 1986: 7: 284-301.
73. Perego C., Vetrugno GC, De Simoni MG, Algeri S. Aging prolongs the stress-induced release of noradrenaline in rat hypothalamus. Neurosci Lett 1993: 157: 127-30.
74. Swaab DF, Raadsheer FC, Endert E., Hofman MA, Kamphorst W., Ravid R. Increased cortisol levels in aging and Alzheimer's disease in postmortem cerebral spinal fluid. J Neuroendocrinol 1994: 6: 681-87.
75. Lupien S., Lecours AR, Lussier I., Schwartz G., Nair NP, Meaney MJ. Basal cortisol levels and cognitive deficits in human aging. J Neurosci 1994: 14: 2893-903.
76. Mondadori C., Ducret T., Häusler A. Elevated corticosteroid levels block the memory-improving effects of nootropics and cholinomimetics. Psychopharmacology (Berl) 1992: 108: 11-5.
77. De Strooper B., Umans L., van Leuven F., van den Berghe H. Study of the synthesis and secretion of normal and artificial mutants of murine amyloid precursor protein (APP): cleavage of APP occurs in a late compartment of the default secretion pathway. J Cell Biol 1993: 121: 295-304.
78. Roher AE, Lowenson JD, Clarke S. et al. Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J Biol Chem 1993: 268: 3072-83.
79. Zhang H., Sternberger NH, Rubinstein LJ, Herman MM, Binder LI, Sternberger LA. Abnormal processing of multiple proteins in Alzheimer disease. Proc Natl Acad Sci USA 1989: 86: 8045-49.
80. Hardy J., Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol Sci 1991: 12: 383-88.
81. Mattson MP, Rydel RE. β-amyloid precursor protein and Alzheimer's disease: the peptide plot thickens. Neurobiol Aging 1992: 13: 617-21.
82. Rogers J., Cooper NR, Webster S. et al. Complement activation by beta-amyloid in Alzheimer disease. Proc Natl Acad Sci USA 1992: 89: 10016-20.
83. Bucht G., Adolfsson R., Lithner F., Winblad B. Changes in blood glucose and insulin secretion in patients with senile dementia of Alzheimer type. Acta Med Scand 1983: 213: 387-92.
84. Fujisawa Y., Sasaki K., Akiyama K. Increased insulin levels after OGTT load in peripheral blood and cerebrospinal fluid of patients with dementia of Alzheimer type. Biol Psychiatry 1991: 30: 1219-28.
85. Kurochkin IV, Goto S. Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. FEBS Lett 1994: 345: 33-37.
86. Lee MK, Graham SN, Gold PE. Memory enhancement with posttraining intraventricular glucose injections in rats. Behav Neurosci 1988: 102: 591-95.
87. Manning CA, Parsons MW, Gold PE. Anterograde and retrograde enhancement of 24-h memory by glucose in elderly humans. Behav Neural Biol 1992: 58: 125-30.
88. Manning CA, Ragozzino ME, Gold PE. Glucose enhancement of memory in patients with probable senile dementia of the Alzheimer's type. Neurobiol Aging 1993: 14: 523-28.
89. Messier C., Destrade C. Insulin attenuates scopolamine-induced memory deficits. Psychobiology 1994: 22: 16-21.
90. Zhu CZ, Auer RN. Intraventricular administration of insulin and IGF-1 in transient forebrain ischemia. J Cereb Blood Flow Metab 1994: 14: 237-42.